These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 33629769)
1. A new MMP-mediated prodomain cleavage mechanism to activate bone morphogenetic proteins from the extracellular matrix. Furlan AG; Spanou CES; Godwin ARF; Wohl AP; Zimmermann LA; Imhof T; Koch M; Baldock C; Sengle G FASEB J; 2021 Mar; 35(3):e21353. PubMed ID: 33629769 [TBL] [Abstract][Full Text] [Related]
2. Targeting of bone morphogenetic protein complexes to heparin/heparan sulfate glycosaminoglycans in bioactive conformation. Spanou CES; Wohl AP; Doherr S; Correns A; Sonntag N; Lütke S; Mörgelin M; Imhof T; Gebauer JM; Baumann U; Grobe K; Koch M; Sengle G FASEB J; 2023 Jan; 37(1):e22717. PubMed ID: 36563024 [TBL] [Abstract][Full Text] [Related]
3. Extracellular Regulation of Bone Morphogenetic Protein Activity by the Microfibril Component Fibrillin-1. Wohl AP; Troilo H; Collins RF; Baldock C; Sengle G J Biol Chem; 2016 Jun; 291(24):12732-12746. PubMed ID: 27059954 [TBL] [Abstract][Full Text] [Related]
4. The prodomain of BMP-7 targets the BMP-7 complex to the extracellular matrix. Gregory KE; Ono RN; Charbonneau NL; Kuo CL; Keene DR; Bächinger HP; Sakai LY J Biol Chem; 2005 Jul; 280(30):27970-80. PubMed ID: 15929982 [TBL] [Abstract][Full Text] [Related]
5. Targeting of bone morphogenetic protein growth factor complexes to fibrillin. Sengle G; Charbonneau NL; Ono RN; Sasaki T; Alvarez J; Keene DR; Bächinger HP; Sakai LY J Biol Chem; 2008 May; 283(20):13874-88. PubMed ID: 18339631 [TBL] [Abstract][Full Text] [Related]
6. Controlling BMP growth factor bioavailability: The extracellular matrix as multi skilled platform. Zimmermann LA; Correns A; Furlan AG; Spanou CES; Sengle G Cell Signal; 2021 Sep; 85():110071. PubMed ID: 34217834 [TBL] [Abstract][Full Text] [Related]
7. Bone morphogenetic proteins, extracellular matrix, and mitogen-activated protein kinase signaling pathways are required for osteoblast-specific gene expression and differentiation in MC3T3-E1 cells. Xiao G; Gopalakrishnan R; Jiang D; Reith E; Benson MD; Franceschi RT J Bone Miner Res; 2002 Jan; 17(1):101-10. PubMed ID: 11771655 [TBL] [Abstract][Full Text] [Related]
8. Bone morphogenetic protein (BMP)-4 and BMP-7 regulate differentially transforming growth factor (TGF)-beta1 in normal human lung fibroblasts (NHLF). Pegorier S; Campbell GA; Kay AB; Lloyd CM Respir Res; 2010 Jun; 11(1):85. PubMed ID: 20573231 [TBL] [Abstract][Full Text] [Related]
9. A new model for growth factor activation: type II receptors compete with the prodomain for BMP-7. Sengle G; Ono RN; Lyons KM; Bächinger HP; Sakai LY J Mol Biol; 2008 Sep; 381(4):1025-39. PubMed ID: 18621057 [TBL] [Abstract][Full Text] [Related]
10. Paired basic/Furin-like proprotein convertase cleavage of Pro-BMP-1 in the trans-Golgi network. Leighton M; Kadler KE J Biol Chem; 2003 May; 278(20):18478-84. PubMed ID: 12637569 [TBL] [Abstract][Full Text] [Related]
11. Regulation of matrix metalloproteinase-13 and tissue inhibitor of matrix metalloproteinase-1 gene expression by WNT3A and bone morphogenetic protein-2 in osteoblastic differentiation. Nakashima A; Tamura M Front Biosci; 2006 May; 11():1667-78. PubMed ID: 16368545 [TBL] [Abstract][Full Text] [Related]
12. Extracellular regulation of BMP signaling: welcome to the matrix. Sedlmeier G; Sleeman JP Biochem Soc Trans; 2017 Feb; 45(1):173-181. PubMed ID: 28202671 [TBL] [Abstract][Full Text] [Related]
13. Bone morphogenetic protein-1/Tolloid-like proteinases process dentin matrix protein-1. Steiglitz BM; Ayala M; Narayanan K; George A; Greenspan DS J Biol Chem; 2004 Jan; 279(2):980-6. PubMed ID: 14578349 [TBL] [Abstract][Full Text] [Related]
14. Prodomains of transforming growth factor beta (TGFbeta) superfamily members specify different functions: extracellular matrix interactions and growth factor bioavailability. Sengle G; Ono RN; Sasaki T; Sakai LY J Biol Chem; 2011 Feb; 286(7):5087-99. PubMed ID: 21135108 [TBL] [Abstract][Full Text] [Related]
15. Bone morphogenetic proteins. Chen D; Zhao M; Mundy GR Growth Factors; 2004 Dec; 22(4):233-41. PubMed ID: 15621726 [TBL] [Abstract][Full Text] [Related]
16. Identification of the growth factor-binding sequence in the extracellular matrix protein MAGP-1. Broekelmann TJ; Bodmer NK; Mecham RP J Biol Chem; 2020 Feb; 295(9):2687-2697. PubMed ID: 31988245 [TBL] [Abstract][Full Text] [Related]
17. Effect of bone morphogenetic protein-2 (BMP-2) on matrix production, other BMPs, and BMP receptors in rat intervertebral disc cells. Li J; Yoon ST; Hutton WC J Spinal Disord Tech; 2004 Oct; 17(5):423-8. PubMed ID: 15385883 [TBL] [Abstract][Full Text] [Related]
18. Developmental roles of the BMP1/TLD metalloproteinases. Ge G; Greenspan DS Birth Defects Res C Embryo Today; 2006 Mar; 78(1):47-68. PubMed ID: 16622848 [TBL] [Abstract][Full Text] [Related]
19. Prediction of heparin binding sites in bone morphogenetic proteins (BMPs). Gandhi NS; Mancera RL Biochim Biophys Acta; 2012 Dec; 1824(12):1374-81. PubMed ID: 22824487 [TBL] [Abstract][Full Text] [Related]
20. [Transfection of recombinant bone morphogenetic protein-7 expressing plasmid into cultured human renal tubular epithelial cells attenuates the extracellular matrix accumulation induced by transforming growth factor-beta]. Li Y; Chen N; Yu HJ; Dong XP; Huang QH Zhonghua Yi Xue Za Zhi; 2006 Feb; 86(8):544-8. PubMed ID: 16681885 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]